
IndraLab
Statements
reach
"The data in our report demonstrated that ATO treatment reduces the binding of USP10 to FLT3 protein, which might partly contribute to the enhanced ubiquitination of mutant FLT3 protein.Hsp90 is an important chaperone molecule assisting in folding and preventing client proteins from ubiquitination and degradation [44]."